Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The treatment successfully lowered testosterone levels and reduced symptoms.

Matriptase imbalance contributes to cancer development and spread.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Immunoadsorption successfully treated a man's resistant polymyositis.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

High TNF-α levels may increase hair loss risk after PRP therapy.

A rare pigmented skin tumor called melanotrichoblastoma was diagnosed in a 51-year-old woman.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Oral tofacitinib successfully treated total body hair loss in one patient.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

Ustekinumab helped three kids with alopecia areata regrow hair.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.